Literature DB >> 1372458

Primary thymic carcinoid with Cushing's syndrome.

G Wollensak1, E W Herbst, A Beck, H E Schaefer.   

Abstract

In a 52-year-old Caucasian man osteopoikilosis had been misdiagnosed roentgenologically 2 years before his death. Gradually he developed Cushing's syndrome and ultimately superior vena caval obstruction. At autopsy a primary thymic carcinoid with extensive osteoblastic bone metastasis was found. Immunohistochemically the tumor was shown to be positive for adrenocorticotropic hormone (ACTH), cytokeratin (KL1), neuron-specific enolase, synaptophysin, chromogranin and glucagon. Remarkably the tumour was negative for serotonin despite high urinary hydroxyindolacetic acid levels. Bilateral hyperplasia of the adrenal cortex was found. The adenohypophysis showed a considerable reduction of ACTH-producing cells and numerous Crooke's cells with a characteristic immunohistochemical pattern.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372458     DOI: 10.1007/bf02358812

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  45 in total

1.  [ADRENAL HYPERCORTICISM AND THYMIC CANCER].

Authors:  J WARTER; A BATZENSCHLAGER; L ASCH; J L WIEDERKEHR
Journal:  Presse Med       Date:  1965-06-23       Impact factor: 1.228

2.  [Malignant thymoma with hypercorticism. Clinical and biological study, both pre- and postoperative].

Authors:  J P Luton; F Girard; M T Pham-Huu-Trung; M Binoux; J Leprat
Journal:  Ann Med Interne (Paris)       Date:  1970-01

3.  Carcinoid tumour of the thymus with systemic manifestations: a radiological and pathological study.

Authors:  R M Lowenthal; J M Gumpel; L Kreel; J E McLaughlin; D B Skeggs
Journal:  Thorax       Date:  1974-09       Impact factor: 9.139

4.  Pituitary-adrenocortical studies in a patient with Cushing's syndrome induced by thymoma.

Authors:  K Miura; C Sasaki; I Katsushima; T Ohtomo; S Sato; H Demura; T Torikai; N Sasano
Journal:  J Clin Endocrinol Metab       Date:  1967-05       Impact factor: 5.958

Review 5.  Neuroendocrine tumor markers.

Authors:  P U Heitz
Journal:  Curr Top Pathol       Date:  1987

6.  Melanocytic neuroendocrine carcinoma of the thymus.

Authors:  W Lagrange; H H Dahm; J Karstens; J Feichtinger; C Mittermayer
Journal:  Cancer       Date:  1987-02-01       Impact factor: 6.860

7.  Carcinoid tumors of the thymus. An immunohistochemical study.

Authors:  W M Herbst; W Kummer; W Hofmann; H Otto; C Heym
Journal:  Cancer       Date:  1987-11-15       Impact factor: 6.860

8.  Carcinoid tumor of the thymus associated with a parathyroid adenoma.

Authors:  J D Vener; L Zuckerbraun; D Goodman
Journal:  Arch Otolaryngol       Date:  1982-05

9.  Ectopic hormone production by endocrine tumors: localization of hormones at the cellular level by immunocytochemistry.

Authors:  P U Heitz; G Klöppel; J M Polak; J J Staub
Journal:  Cancer       Date:  1981-11-01       Impact factor: 6.860

10.  Pigmented carcinoid tumour of the thymus.

Authors:  F C Ho; J C Ho
Journal:  Histopathology       Date:  1977-09       Impact factor: 5.087

View more
  4 in total

Review 1.  The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors.

Authors:  P Rosa; H H Gerdes
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

2.  Carcinoid tumours of the thymus.

Authors:  D Y Wang; D B Chang; S H Kuo; P C Yang; Y C Lee; H C Hsu; K T Luh
Journal:  Thorax       Date:  1994-04       Impact factor: 9.139

Review 3.  Ectopic Cushing's syndrome due to thymic neuroendocrine tumours: a systematic review.

Authors:  Fernando Guerrero-Pérez; Inmaculada Peiró; Agustina Pia Marengo; Alex Teulé; José Carlos Ruffinelli; Roger Llatjos; Teresa Serrano; Ivan Macia; Nuria Vilarrasa; Pedro Iglesias; Carles Villabona
Journal:  Rev Endocr Metab Disord       Date:  2021-05-07       Impact factor: 6.514

4.  CT/MRI of neuroendocrine tumours.

Authors:  Rodney H Reznek
Journal:  Cancer Imaging       Date:  2006-10-31       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.